Rein Therapeutics, Inc. · NASDAQ:RNTX
Rein Therapeutics, Inc. shareholders
As of Jun 30, 2026, 58 institutions reported holding Rein Therapeutics, Inc., 47.3% of its shares. Largest: Voss Capital, LP, Cable Car Capital, LP and ADAR1 Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Rein Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Voss Capital, LP | 5.26M | 6.1% | +874K | Aug 14, 2026 |
| Cable Car Capital, LP | 5.2M | 6.0% | +4.78M | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | 4.5M | 5.2% | new | Aug 14, 2026 |
| Vanguard | 3.77M | 4.4% | +2.61M | Aug 13, 2026 |
| BIOS Capital Management, LP | 2.98M | 3.5% | +1M | Aug 14, 2026 |
| Ikarian Capital, LLC | 2.95M | 3.4% | new | Aug 14, 2026 |
| Great Point Partners LLC | 2.58M | 3.0% | new | Aug 14, 2026 |
| Citadel | 2.44M | 2.8% | new | Aug 14, 2026 |
| Velan Capital Investment Management LP | 1.7M | 2.0% | new | Aug 14, 2026 |
| Senvest Management, LLC | 1.23M | 1.4% | +1M | Aug 14, 2026 |